QA: Genelux Corp in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001231457_2024_Genelux_Corp.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001231457, Genelux Corp

  xvar xval
0 AssetsCurrent 24,203,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,170,000
3 remainder_Assets 2,520,000
4 LiabilitiesCurrent 6,554,000
5 LiabilitiesNoncurrent 1,866,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 11,568,000
9 ResearchAndDevelopmentExpense 12,767,000
10 remainder_Expenses 0
11 remainder_Revenues 170,000
12 remainder_NetIncome -4,132,000
13 remainder_ComprehensiveNetIncome 12,000
  yvar yval
0 Assets 27,893,000
1 Liabilities 8,420,000
2 Expenses 24,335,000
3 Revenues 170,000
4 StockholdersEquity 19,473,000
5 NetIncome -28,297,000
6 ComprehensiveNetIncome -28,291,000
7 BaseVar 32,481,000
8 EconomicCapitalRatiobeforeLimitedLiability 0.780
9 EconomicCapitalRatio 2.12

Edgar->Model Mapping

Feature Distribution